Literature DB >> 16690233

Growth and development of children conceived by in-vitro maturation of human oocytes.

Mu Shu-Chi1, Hwang Jiann-Loung, Lin Yu-Hung, Sung Tseng-Chen, Lin Ming-I, Yeh Tsu-Fuh.   

Abstract

AIMS: The objective of this study is to evaluate the physical and mental development of infants born on in-vitro maturation (IVM) programs. STUDY
DESIGN: We compare 21 IVM children as study group and 21 non-IVM children as control group. We performed a general physical examination for malformations, neurological examination, developmental examination (Bayley Scales) on the IVM group and the non-IVM group.
RESULTS: We found all the children with normal karyotype and without major malformation in both IVM and non-IVM groups. The mean Mental Development Index scores for IVM subjects and the comparison group were 92.71+/-10.47 and 97.19+/-8.88, respectively (p=0.074). The mean Psychomotor Development Index scores were 96.67+/-8.91 and 96.19+/-7.05, respectively (p=0.817).
CONCLUSIONS: This is the first study designed to evaluate the physical growth and developmental indices of IVM children with combinational priming protocol of FSH and hCG. Our results suggest that IVM children didn't show developmental delay during infancy and early childhood.

Entities:  

Mesh:

Year:  2006        PMID: 16690233     DOI: 10.1016/j.earlhumdev.2006.01.012

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  12 in total

1.  Health of IVM children.

Authors:  Emre Basatemur; Alastair Sutcliffe
Journal:  J Assist Reprod Genet       Date:  2011-04-07       Impact factor: 3.412

2.  Development of children born after in vitro maturation with a prematuration step versus natural conception: a prospective cohort study.

Authors:  Duy L Nguyen; Nghia A Nguyen; Toan D Pham; Minh H N Nguyen; Lan N Vuong
Journal:  J Assist Reprod Genet       Date:  2022-07-07       Impact factor: 3.357

3.  Oncofertility in Canada: cryopreservation and alternative options for future parenthood.

Authors:  R Ronn; H E G Holzer
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

Review 4.  An overview of studies on psychological well-being in children born following assisted reproductive technologies.

Authors:  Qi-tao Zhan; Pei-pei Pan; Xiang-rong Xu; Hang-ying Lou; Yi-yun Lou; Fan Jin
Journal:  J Zhejiang Univ Sci B       Date:  2013-11       Impact factor: 3.066

Review 5.  In Vitro Maturation in Women with vs. without Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Charalampos Siristatidis; Theodoros N Sergentanis; Paraskevi Vogiatzi; Prodromos Kanavidis; Charalampos Chrelias; Nikolaos Papantoniou; Theodora Psaltopoulou
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

Review 6.  In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities.

Authors:  Eun Mi Chang; Hang Seok Song; Dong Ryul Lee; Woo Sik Lee; Tae Ki Yoon
Journal:  Clin Exp Reprod Med       Date:  2014-06-30

Review 7.  Perspectives on the development and future of oocyte IVM in clinical practice.

Authors:  Michel De Vos; Michaël Grynberg; Tuong M Ho; Ye Yuan; David F Albertini; Robert B Gilchrist
Journal:  J Assist Reprod Genet       Date:  2021-07-03       Impact factor: 3.412

8.  In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.

Authors:  Charalampos S Siristatidis; Abha Maheshwari; Dennis Vaidakis; Siladitya Bhattacharya
Journal:  Cochrane Database Syst Rev       Date:  2018-11-15

9.  Growth development of French children born after in vitro maturation.

Authors:  Laurence Foix-L'Hélias; Michael Grynberg; Béatrice Ducot; Nelly Frydman; Violaine Kerbrat; Jean Bouyer; Philippe Labrune
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

10.  Chromosomal aberrations in in-vitro matured oocytes influence implantation and ongoing pregnancy rates in a mouse model undergoing intracytoplasmic sperm injection.

Authors:  Min Li; Hong-Cui Zhao; Rong Li; Yang Yu; Jie Qiao
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.